1987
DOI: 10.1016/0165-4608(87)90262-7
|View full text |Cite
|
Sign up to set email alerts
|

Trisomy 9 in hematologic disorders: Possible association with primary thrombocytosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
1
0

Year Published

1989
1989
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 33 publications
1
1
0
Order By: Relevance
“…The rarity with which trisomy 9 occurs, either alone or in association with other cytogenetic abnormalities, suggest that it may not be a primary event in the pathogenesis of leukemia, but a secondary anomaly associated with clonal evolution of the disease. 8 The presence of inv16 and Trisomy 9 has been reported in earlier studies ( Table 1 ).…”
Section: Discussionsupporting
confidence: 70%
“…The rarity with which trisomy 9 occurs, either alone or in association with other cytogenetic abnormalities, suggest that it may not be a primary event in the pathogenesis of leukemia, but a secondary anomaly associated with clonal evolution of the disease. 8 The presence of inv16 and Trisomy 9 has been reported in earlier studies ( Table 1 ).…”
Section: Discussionsupporting
confidence: 70%
“…This hypothesis is supported by the fact that hematopoietic stem cell transplantation has alleviated MDS with SPAP patients [ 16 ]. In contrast, trisomy 9 is rarely reported and is chiefly associated with myeloproliferative and myelodysplastic disorders, such as MDS [ 20 ]. Disrupted GM-CSF signaling is a major cause of PAP.…”
Section: Discussionmentioning
confidence: 99%